CompletedPhase 3NCT02929121
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Task Force for Global Health
- Principal Investigator
- Eric Ottesen, MDThe Task Force for Global Health
- Intervention
- Doxycycline(drug)
- Enrollment
- 235 enrolled
- Eligibility
- 14-65 years · All sexes
- Timeline
- 2019 – 2021
Study locations (1)
- Filariasis Research Unit Govt. T. D. Medical College Hospital, Alappuzha, Kerala, India
Collaborators
United States Agency for International Development (USAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02929121 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.